Literature DB >> 6129365

Cyclosporin prevents diabetes in BB Wistar rats.

A Laupacis, C R Stiller, C Gardell, P Keown, J Dupre, A C Wallace, P Thibert.   

Abstract

Cyclosporin (U.S.A.N. cyclosporine) was used prophylactically to suppress the development of insulin-dependent diabetes mellitus in BB Wistar rats. In this rat strain diabetes spontaneously develops between 60 and 120 days of age and this condition resembles human type 1 diabetes. In 30 (75%) out of 40 control rats glycosuria and hyperglycaemia developed and these rats became insulin-dependent. Their pancreases showed partial to complete destruction of the islets of Langerhans by lymphocytic infiltration. None of the 40 cyclosporin-treated rats became diabetic and their pancreases were histologically normal. Serum cyclosporin was monitored in a subgroup and the dosage was adjusted accordingly; neither hepatotoxicity nor nephrotoxicity was seen in the treated animals.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6129365     DOI: 10.1016/s0140-6736(83)91558-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  54 in total

1.  Liver transplantation for diethylnitrosamine-induced hepatocellular carcinoma in rats.

Authors:  T Matsuzaki; N Murase; A Yagihashi; H Shinozuka; Y Shimizu; T Furuya; N Burrell; S Iwatsuki; T E Starzl
Journal:  Transplant Proc       Date:  1992-04       Impact factor: 1.066

Review 2.  Emerging indications for the use of cyclosporin in organ transplantation and autoimmunity.

Authors:  P A Keown
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

3.  Cyclosporin A in the prevention and treatment of experimental autoimmune glomerulonephritis in the brown Norway rat.

Authors:  J Reynolds; S J Cashman; D J Evans; C D Pusey
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

4.  A delayed-type hypersensitivity skin-test system using the insulinoma cell line RINm5F to monitor beta cell-specific cellular autoimmune reactivity in the spontaneously diabetic BB/O rat.

Authors:  H A Voorby; P H Jeucken; H A Drexhage
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

5.  Diabetes mellitus in the BB/W rat. Insulitis in pancreatic islet grafts after transplantation in diabetic recipients.

Authors:  E J Weringer; A A Like
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

Review 6.  Prediction and prevention of type I diabetes.

Authors:  R Gianani; G S Eisenbarth
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

7.  Long-term effects of cyclosporin A on cultured mouse pancreatic islets.

Authors:  A Andersson; H Borg; A Hallberg; C Hellerström; S Sandler; A Schnell
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

8.  Prevention of diabetes mellitus in the BB/W rat with Cyclosporin-A.

Authors:  A A Like; V Dirodi; S Thomas; D L Guberski; A A Rossini
Journal:  Am J Pathol       Date:  1984-10       Impact factor: 4.307

9.  Neonatal injections of cyclosporin enhance autoimmune diabetes in non-obese diabetic mice.

Authors:  P Saï; O Senecat; L Martignat; E Gouin
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

10.  Islet cell surface and lymphocyte antibodies often precede the spontaneous diabetes in the BB rat.

Authors:  T Dyrberg; P Poussier; F Nakhooda; E B Marliss; A Lernmark
Journal:  Diabetologia       Date:  1984-02       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.